About the Authors
- Lander Egaña-Gorroño
-
Affiliation Group of Genomics and Pharmacogenomics, AIDS Research Group, Catalan project for the development of an HIV vaccine (HIVACAT), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic de Barcelona, Barcelona, Spain
- Tuixent Escribà
-
Affiliation Group of Genomics and Pharmacogenomics, AIDS Research Group, Catalan project for the development of an HIV vaccine (HIVACAT), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic de Barcelona, Barcelona, Spain
- Nicolas Boulanger
-
Affiliations Group of Genomics and Pharmacogenomics, AIDS Research Group, Catalan project for the development of an HIV vaccine (HIVACAT), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic de Barcelona, Barcelona, Spain, Centro Nacional de Análisis Genómico, Scientific Park of Barcelona, Barcelona, Spain
- Alberto Crespo Guardo
-
Affiliation Immunopathology and Cellular Immunology, AIDS Research Group, Catalan project for the development of an HIV vaccine (HIVACAT), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic de Barcelona, Barcelona, Spain
- Agathe León
-
Affiliation Department of Infectious Diseases, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain
- Manel Enric Bargalló
-
Affiliation Immunopathology and Cellular Immunology, AIDS Research Group, Catalan project for the development of an HIV vaccine (HIVACAT), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic de Barcelona, Barcelona, Spain
- Felipe Garcia
-
Affiliation Department of Infectious Diseases, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain
- José María Gatell
-
Affiliation Department of Infectious Diseases, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain
- Montserrat Plana
-
Contributed equally to this work with: Montserrat Plana, Mireia Arnedo
Affiliation Immunopathology and Cellular Immunology, AIDS Research Group, Catalan project for the development of an HIV vaccine (HIVACAT), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic de Barcelona, Barcelona, Spain
- Mireia Arnedo
-
Contributed equally to this work with: Montserrat Plana, Mireia Arnedo
* E-mail: marnedo@clinic.ub.es
Affiliation Group of Genomics and Pharmacogenomics, AIDS Research Group, Catalan project for the development of an HIV vaccine (HIVACAT), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic de Barcelona, Barcelona, Spain
- HIV Controllers Consortium of the AIDS Spanish Network
-
¶Membership of the HIV Controllers Consortium of the AIDS Spanish Network is provided in the Acknowledgments.
Competing Interests
The authors have declared that no competing interests exist.
Author Contributions
Conceived and designed the experiments: MA MP. Performed the experiments: LE TE NB MEB. Analyzed the data: MA LE NB. Wrote the paper: MA LE ACG MP JMG FG. Provided samples and collected data: FG AL. Critically revised and subsequently approved the final version: MA MP LE TE NB MEB ACG JMG FG AL.